drugset / Trial / NCT00781664

Cumulative Irritation Test

NCT00781664 ↗

Phase 1 Completed 44 enrolled Pfizer
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

Timeline

Start
2008-10
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AN2718 Small molecule 0.3 % Topical
Subject AN2718 Small molecule 1 % Topical
Subject AN2718 Small molecule 1.5 % Topical
Subject AN2718 Small molecule 2.5 % Topical
Subject AN2718 Small molecule 5 % Topical
Subject AN2718 Small molecule 7.5 % Topical

Indications